Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Smartphone test predicts how symptoms develop in Parkinson’s

General Research

Researchers in Nuffield Department of Clinical Neurosciences have found that a simple test carried out on a smartphone can help to predict future change in people in the early stages of Parkinson’s.

This study, supported by the NIHR Oxford Biomedical Research Centre (BRC) and funded by the Monument Trust Discovery Award from Parkinson's UK, has the potential to foster a more personalised approach to the treatment of Parkinson’s and allow clinicians to target interventions to those individuals most likely to benefit.

The smartphone test guides users through seven tasks assessing voice, balance, walking, reaction time, finger tapping, rest tremor and postural tremor.

The test, which takes around seven minutes in total to perform, makes use of the sensors in smartphones to measure different kinds of movement consistently and accurately.

Read more (Nuffield Department of Clinical Neurosciences website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Tinnitus seems linked with sleep – understanding how could bring us closer to finding a cure

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.